CLINICAL_TRIALS
trial_result
· 2012-09-17
Clinical Trial Update: Safety and Efficacy Study of Ara-c at 18 gm/m2 Versus 12 gm/m2 for 3 Cycles Each in AML Consolidation [Phase 3]
Summary
Phase 3 clinical trial comparing Ara-C at 18 g/m2 vs 12 g/m2 for 3 cycles as consolidation in acute myeloid leukemia; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: All India Institute of Medical Sciences | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN